Advisor Group Holdings, Inc. Evogene Ltd. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.61 - $0.82 $1,845 - $2,480	-3,025 Reduced 35.91%	5,400 $3,000
Q3 2023 Nov 13, 2023	SELL	$0.58 - $1.41 $290 - $705	-500 Reduced 5.6%	8,425 $4,000
Q2 2022 Aug 10, 2022	BUY	$0.75 - $1.33 $1,125 - $1,995	1,500 Added 20.2%	8,925 $6,000
Q3 2021 Nov 05, 2021	BUY	$2.45 - $3.45 $1,286 - $1,811	525 Added 7.61%	7,425 $20,000
Q1 2021 May 13, 2021	BUY	$4.29 - $9.94 $27,893 - $64,629	6,502 Added 1633.67%	6,900 $35,000
Q4 2020 Feb 10, 2021	BUY	$2.41 - $5.63 $106 - $247	44 Added 12.43%	398 $2,000
Q3 2020 Nov 12, 2020	BUY	$0.97 - $4.08 $73 - $310	76 Added 27.34%	354 $1,000
Q2 2020 Aug 14, 2020	BUY	$0.92 - $1.29 $233 - $327	254 Added 1058.33%	278 $0
Q1 2020 May 18, 2020	BUY	$0.75 - $1.81 $18 - $43	24 New	24 $0

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $61M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.